Can aspirin exacerbate asthma, especially in individuals with aspirin‑sensitive or aspirin‑exacerbated respiratory disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, aspirin can worsen asthma in susceptible individuals, particularly those with aspirin-exacerbated respiratory disease (AERD).

Aspirin and other COX-1 inhibiting NSAIDs can trigger severe, acute respiratory reactions in approximately 7-9% of adults with asthma, causing sudden bronchospasm, dyspnea, and potentially life-threatening exacerbations 1, 2. The FDA drug label explicitly warns that aspirin may cause asthma (wheezing) as part of a severe allergic reaction 3.

Understanding the Risk Profile

AERD represents a distinct clinical syndrome characterized by:

  • Chronic rhinosinusitis with nasal polyposis
  • Asthma (often moderate to severe)
  • Acute respiratory reactions to aspirin and COX-1 inhibiting NSAIDs
  • Onset typically in adulthood, rare in children 1

The prevalence data is clear: approximately 7% of all adults with asthma and one-third of patients with both asthma and nasal polyps have AERD 1. When measured through controlled oral provocation challenge tests, the prevalence is 9.0%, closely matching the 9.9% prevalence from patient-reported history 2.

Clinical Presentation and Severity

Respiratory reactions typically occur within 3 hours of aspirin ingestion 4. The average provocative dose triggering reactions is 85.8 mg—well below a standard 325 mg tablet 2. This means even low-dose aspirin can trigger reactions.

The impact on asthma morbidity is substantial:

  • 2-fold increased risk of uncontrolled asthma
  • 60% increased risk of severe asthma and asthma attacks
  • 80% increased risk of emergency room visits
  • 40% increased risk of hospitalization 2

These patients often require repeated sinus surgeries and frequent systemic corticosteroids even when avoiding aspirin, as the underlying inflammatory disease progresses independently of NSAID exposure 1, 5.

High-Risk Identification

Advise patients with severe persistent asthma, nasal polyps, or a history of sensitivity to aspirin or NSAIDs about their risk of severe and even fatal exacerbations from using these drugs 6. The combination of asthma plus nasal polyps should immediately raise suspicion for AERD.

Safe Alternatives

Selective COX-2 inhibitors (coxibs) can be used safely as alternative analgesics in patients with any NSAID hypersensitivity phenotype 1. These medications are extremely rare causes of reactions in AERD patients because they do not inhibit COX-1 1, 7. Acetaminophen up to 650 mg or weak COX-1 inhibitors like sodium salicylate can also be used 8.

Diagnostic Approach

Neither skin testing nor in vitro tests are useful for AERD 1. Diagnosis relies on:

  • Clinical history of asthma with chronic rhinosinusitis
  • Presence of nasal polyps
  • History of respiratory reactions to aspirin/NSAIDs
  • Formal oral provocation challenge when history is unclear (80-100% positive predictive value with typical history) 1

Management Considerations

For patients with confirmed AERD requiring aspirin for cardiovascular or other indications, aspirin desensitization followed by daily aspirin therapy is the gold standard treatment 5, 7. This approach improves symptom scores, reduces systemic corticosteroid requirements, and slows polyp regrowth 5. However, this requires specialized protocols and should only be performed by experienced allergists.

The key pitfall is underrecognition: many AERD patients remain undiagnosed 9. Any adult with difficult-to-control asthma and nasal polyps should be specifically questioned about reactions to aspirin or NSAIDs, as this population faces significantly higher morbidity and healthcare utilization.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.